| scholarly article | Q13442814 |
| P50 | author | Thomas Kietzmann | Q40434619 |
| P2093 | author name string | Ehrenreich H | |
| Sirén AL | |||
| Kuhn HJ | |||
| Knabe W | |||
| Knerlich F | |||
| Brunnett G | |||
| Washausen S | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | erythropoietin | Q218706 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 503-512 | |
| P577 | publication date | 2004-02-10 | |
| P1433 | published in | Anatomy and Embryology | Q1983570 |
| P1476 | title | Expression patterns of erythropoietin and its receptor in the developing midbrain | |
| P478 | volume | 207 |
| Q28574476 | A hematopoietic growth factor, thrombopoietin, has a proapoptotic role in the brain |
| Q30950859 | A novel role for an established player: anemia drug erythropoietin for the treatment of cerebral hypoxia/ischemia |
| Q49375977 | Alternative Erythropoietin Receptors in the Nervous System |
| Q59796441 | Astrocyte HIF-2α supports learning in a passive avoidance paradigm under hypoxic stress |
| Q48403988 | Cell type specific signalling by hematopoietic growth factors in neural cells |
| Q34026944 | Complex pattern of interaction between in utero hypoxia-ischemia and intra-amniotic inflammation disrupts brain development and motor function. |
| Q51871689 | Effects of epidermal growth factor and erythropoietin on Müller glial activation and phenotypic plasticity in the adult mammalian retina. |
| Q48119740 | Endogenous erythropoietin signaling is required for normal neural progenitor cell proliferation |
| Q38172120 | Enhancement of ventricular-subventricular zone-derived neurogenesis and oligodendrogenesis by erythropoietin and its derivatives |
| Q36520524 | Erythropoietin Modulates Cerebral and Serum Degradation Products from Excess Calpain Activation following Prenatal Hypoxia-Ischemia |
| Q47146719 | Erythropoietin Signaling Regulates Key Epigenetic and Transcription Networks in Fetal Neural Progenitor Cells |
| Q52369778 | Erythropoietin Upregulates Brain Hemoglobin Expression and Supports Neuronal Mitochondrial Activity. |
| Q33907747 | Erythropoietin action in stress response, tissue maintenance and metabolism |
| Q33890267 | Erythropoietin improves neurobehavior by reducing dopaminergic neuron loss in a 6‑hydroxydopamine‑induced rat model |
| Q35909929 | Erythropoietin in brain development and beyond |
| Q40227953 | Erythropoietin in cerebrospinal fluid: age-related reference values and relevance in neurological disease |
| Q28573061 | Erythropoietin receptor expression is concordant with erythropoietin but not with common beta chain expression in the rat brain throughout the life span |
| Q34768481 | Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma. |
| Q37396967 | Erythropoietin signaling promotes oligodendrocyte development following prenatal systemic hypoxic-ischemic brain injury |
| Q42922791 | Erythropoietin: a multimodal neuroprotective agent |
| Q35956310 | Erythropoietin: novel approaches to neuroprotection in human brain disease |
| Q30475059 | Expression of constitutively active erythropoietin receptor in pyramidal neurons of cortex and hippocampus boosts higher cognitive functions in mice |
| Q40103316 | Expression of erythropoietin and its receptor in neuroblastomas |
| Q55413545 | Extended Erythropoietin Treatment Prevents Chronic Executive Functional and Microstructural Deficits Following Early Severe Traumatic Brain Injury in Rats. |
| Q35083677 | Functional erythropoietin autocrine loop in melanoma |
| Q37724782 | Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury. |
| Q47216442 | Neonatal erythropoietin mitigates impaired gait, social interaction and diffusion tensor imaging abnormalities in a rat model of prenatal brain injury |
| Q38188856 | Neuroprotective effects of erythropoiesis-stimulating agents in term and preterm neonates |
| Q34569855 | Postnatal erythropoietin treatment mitigates neural cell loss after systemic prenatal hypoxic-ischemic injury |
| Q41333380 | Protective effect of erythropoietin against 1-methyl-4-phenylpyridinium-induced neurodegenaration in PC12 cells |
| Q24649547 | Recent trends in erythropoietin-mediated neuroprotection |
| Q41173431 | Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative Treatment of Multiple Sclerosis |
| Q36153802 | Role of erythropoietin in the brain |
| Q37817069 | Seeing old friends from a different angle: novel properties of hematopoietic growth factors in the healthy and diseased brain |
| Q39850166 | The construction of siRNA plasmid targeting mouse HIF-1alpha and in vitro study of its inhibition effect |
| Q34291437 | The effect of erythropoietin on normal and neoplastic cells |
| Q37358669 | Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system |
| Q37263628 | Trophic factors in the carotid body |
| Q90343897 | Updates on Novel Erythropoiesis-Stimulating Agents: Clinical and Molecular Approach |
| Q42921510 | Up‐regulation of erythropoietin receptor by nitric oxide mediates hypoxia preconditioning |
Search more.